In pathological conditions, including cardiac hypertrophy, chemotherapy-induced cardiotoxicity, diabetic cardiomyopathy, and myocardial infarction (MI), studies suggest that p53 negatively impacts oxidative stress and cardiomyocyte apoptosis [36,37]. Here, TP53 is linked to cardiac hypertrophy.